Chromatin-Bound MDM2 regulates serine metabolism and redox homeostasis independently of p53

Archive ouverte

Riscal, Romain | Schrepfer, Emilie | Arena, Giuseppe | Cisse, Madi Y. | Bellvert, Floriant | Heuillet, Maud | Rambow, Florian | Bonneil, Eric | Sabourdy, Frederique | Vincent, Charles | Ait-Arsa, Imade | Levade, Thierry | Thibaut, Pierre | Marine, Jean-Christophe | Portais, Jean-Charles | Sarry, Jean-Emmanuel | Le Cam, Laurent | Linares, Laetitia K.

Edité par CCSD ; Cell Press -

The mouse double minute 2 (MDM2) oncoprotein is recognized as a major negative regulator of the p53 tumor suppressor, but growing evidence indicates that its oncogenic activities extend beyond p53. Here, we show that MDM2 is recruited to chromatin independently of p53 to regulate a transcriptional program implicated in amino acid metabolism and redox homeostasis. Identification of MDM2 target genes at the whole-genome level highlights an important role for ATF3/4 transcription factors in tethering MDM2 to chromatin. MDM2 recruitment to chromatin is a tightly regulated process that occurs during oxidative stress and serine/glycine deprivation and is modulated by the pyruvate kinase M2 (PKM2) metabolic enzyme. Depletion of endogenous MDM2 in p53-deficient cells impairs serine/glycine metabolism, the NAD(+)/NADH ratio, and glutathione (GSH) recycling, impacting their redox state and tumorigenic potential. Collectively, our data illustrate a previously unsuspected function of chromatin-bound MDM2 in cancer cell metabolism.

Suggestions

Du même auteur

Targeting MDM2-dependent serine metabolism as a therapeutic strategy for liposarcoma

Archive ouverte | Cissé, Madi | CCSD

International audience. Well-differentiated and dedifferentiated liposarcomas (LPSs) are characterized by a systematic amplification of the MDM2 oncogene, which encodes a key negative regulator of the p53 pathway. T...

Mitochondrial MDM2 regulates respiratory complex i activity independently of p53

Archive ouverte | Arena, Giuseppe | CCSD

International audience. Accumulating evidence indicates that the MDM2 oncoprotein promotes tumorigenesis beyond its canonical negative effects on the p53 tumor suppressor, but these p53-independent functions remain ...

Isocitrate dehydrogenase 1 mutations prime the all-trans retinoic acid myeloid differentiation pathway in acute myeloid leukemia

Archive ouverte | Boutzen, Héléna | CCSD

International audience. Acute myeloid leukemia (AML) is characterized by the accumulation of malignant blasts with impaired differentiation programs caused by recurrent mutations, such as the isocitrate dehydrogenas...

Chargement des enrichissements...